M Roberts, P A Rinaudo, R C Tilton, J Vilinskas. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntifungal Agents/therapeutic useBrain/pathologyBrain Diseases/complicationsBrain Diseases/drug therapyBrain Diseases/pathologyBrain Diseases/surgeryCryptococcosis/complicationsCryptococcosis/drug therapyCryptococcosis/pathologyCryptococcosis/surgeryCryptococcus neoformans/drug effectsCytosine/therapeutic useFlucytosine/administration & dosageFlucytosine/therapeutic useGranuloma/drug therapyGranuloma/etiologyGranuloma/pathologyGranuloma/surgeryHemiplegia/etiologyHumansMale
Substances： See more » Antifungal AgentsCytosineFlucytosine
Year: 1972 PMID： 4558256 DOI： 10.3171/jns.1972.37.2.0229
Source DB: PubMed Journal: J Neurosurg ISSN： 0022-3085 Impact factor: 5.115